We're proud to announce that we’re joining @InnovateKidney to give patients with end-stage kidney disease access to home dialysis and the clinical and quality of life benefits it offers. Learn more: https://t.co/itwkuYHq6q. #InnovateKidneyCare
@ClickThera announces appointments of Dr. Muzammil Mansuri and Jeffrey Berkowitz as Senior Strategic Advisors and the formation of a Payer Advisory Board, chaired by Mr. Berkowitz. #digitaltherapeutics
https://t.co/Yun7FrhdQ2
“The core of Click Therapeutics is understanding the user’s perspective and building the product in a way that they want to use it.”
@ClickThera featured in this week's @BioCentury emerging company profile:
https://t.co/4PWNs4RN8Q
David Benshoof Klein of @ClickThera explains that there are about 25 different mechanisms of action exploited by the company's digital therapeutics #FT19
"There's are very interesting interventions that you can develop for #digitaltherapeutics that don't exist elsewhere that you couldn't get elsewhere, and the origin of those is from these academic collaborations" @AustinSpeier @ClickThera #BIOEurope
David Benshoof Klein of @ClickThera is talking about how to use digital therapeutics to target multiple indications. These are apps with drug-like labels, so doctors are comfortable prescribing them, he tells #FH19
There are drug-like outcomes from digital therapeutics developed by @ClickThera. Pharma is starting to take notice and treat them like pipeline assets. They also don't have the side effects seen with drugs says CEO David Benshoof Klein at #FH19
Up next is a session on digital therapeutics at #FH19 there will be a keynote from David Benshoof Klein CEO of Click Therapeutics @ClickThera. Digital therapeutics have been clinically validated to show they improve health outcomes